Published in Arch Virol on March 01, 2002
Molecular epidemiology of foot-and-mouth disease viruses in the Adamawa province of Cameroon. J Clin Microbiol (2004) 1.01
Complete Genome Sequence of Foot-and-Mouth Disease Virus Type A Circulating in Bangladesh. Genome Announc (2014) 0.97
Shifts in the selection-drift balance drive the evolution and epidemiology of foot-and-mouth disease virus. J Virol (2008) 0.86
In-vitro and in-vivo phenotype of type Asia 1 foot-and-mouth disease viruses utilizing two non-RGD receptor recognition sites. BMC Microbiol (2011) 0.81
Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development. PLoS One (2013) 0.79
Antigenic heterogeneity of capsid protein VP1 in foot-and-mouth disease virus (FMDV) serotype Asia 1. Adv Appl Bioinform Chem (2013) 0.79
Evolutionary phylodynamics of foot-and-mouth disease virus serotypes O and A circulating in Vietnam. BMC Vet Res (2016) 0.79
Complete Genome Sequence of a Serotype A Foot-and-Mouth Disease Virus from an Outbreak in Saudi Arabia during 2015. Genome Announc (2016) 0.75
Evolutionary Analysis and Prediction of Peptide Vaccine Candidates for Foot-and-Mouth-Disease Virus Types A and O in Bangladesh. Evol Bioinform Online (2014) 0.75
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet (2001) 5.80
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet (2005) 4.65
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Clinical pharmacokinetics of cyclosporin. Clin Pharmacokinet (1986) 3.53
The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. Am J Transplant (2011) 3.42
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc (1990) 2.60
Pregnancy after liver transplantation under tacrolimus. Transplantation (1997) 2.50
Cyclosporine kinetics in renal transplantation. Clin Pharmacol Ther (1985) 2.38
The hepatotropic influence of cyclosporine. Surgery (1990) 2.27
Effect of bile on cyclosporin absorption in liver transplant patients. Br J Clin Pharmacol (1988) 2.21
Tacrolimus: a new immunosuppressive agent. Am J Health Syst Pharm (1995) 1.69
Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem (2001) 1.67
Pharmacokinetics and monitoring of cyclosporine following orthotopic liver transplantation. Semin Liver Dis (1985) 1.61
Cyclosporine Monitoring and Pharmacokinetics in Pediatrie Liver Transplant Patients. Transplant Proc (1985) 1.55
Pharmacokinetics of orally administered ritodrine. Am J Obstet Gynecol (1989) 1.45
Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthritis Cartilage (2003) 1.33
Assay of FK 506 in plasma. Transplant Proc (1990) 1.32
Sensitivity of activated human lymphocytes to cyclosporine and its metabolites. Hum Immunol (1988) 1.31
The use of human hepatocyte cultures to study the induction of cytochrome P-450. Drug Metab Dispos (1999) 1.30
Excretion of cyclosporine and its metabolites in human bile. Transplant Proc (1986) 1.27
Role of bile and bile salts on cyclosporine absorption in dogs. Transplant Proc (1987) 1.24
Pharmacokinetics of FK506 in liver transplant recipients after continuous intravenous infusion. J Clin Pharmacol (1993) 1.23
Comparison of UW with other solutions for liver preservation in dogs. Clin Transplant (1989) 1.20
Practical aspects of FK 506 analysis (Pittsburgh experience). Transplant Proc (1991) 1.19
Genetic typing of recent classical swine fever isolates from India. Vet Microbiol (2009) 1.19
Phylogenetic analysis of NS5B gene of classical swine fever virus isolates indicates plausible Chinese origin of Indian subgroup 2.2 viruses. Virus Genes (2011) 1.12
Localization of chondrocyte precursors in periosteum. Osteoarthritis Cartilage (2001) 1.11
Effect of erythromycin on cyclosporine levels. N Engl J Med (1985) 1.09
Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression. Transplant Proc (1990) 1.08
Cyclosporine absorption following orthotopic liver transplantation. J Clin Pharmacol (1987) 1.07
Antipyrine kinetics in liver disease and liver transplantation. Clin Pharmacol Ther (1986) 1.03
Cyclosporine. Drug Intell Clin Pharm (1985) 1.02
Treating inflammation with the Janus kinase inhibitor CP-690,550. Trends Pharmacol Sci (2010) 1.02
Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem (1998) 1.01
Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients. Antimicrob Agents Chemother (2010) 1.01
FK 506 dosage in human organ transplantation. Transplant Proc (1990) 0.99
The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs. Transplantation (1992) 0.98
Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft-versus-host disease. Bone Marrow Transplant (1991) 0.96
Recent spread of FMD virus serotype Asia 1. Vet Rec (2005) 0.95
Immunosuppressive effect of cyclosporine metabolites from human bile on alloreactive T cells. Transplant Proc (1988) 0.95
Pharmacokinetics of IgG and IgM anti-ganglioside antibodies in rats and monkeys after intrathecal administration. J Pharmacol Exp Ther (1998) 0.95
Genetic diversity in the VP1 gene of foot-and-mouth disease virus serotype Asia 1. Arch Virol (2002) 0.94
Pharmacokinetics and local responses to submucosal meperidine compared with other routes of administration. Pediatr Dent (1994) 0.94
Effect of bile on cyclosporine absorption in dogs. Res Commun Chem Pathol Pharmacol (1986) 0.93
Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. Transplant Proc (1991) 0.93
Voriconazole pharmacokinetics in liver transplant recipients. Antimicrob Agents Chemother (2009) 0.92
Cancer chemotherapy and heterocyclic compounds. Curr Med Chem (2002) 0.92
The role of conjugation in hepatotoxicity of troglitazone in human and porcine hepatocyte cultures. Drug Metab Dispos (2000) 0.92
Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol (1999) 0.92
Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab Invest (1993) 0.92
Periosteum responds to dynamic fluid pressure by proliferating in vitro. J Orthop Res (1999) 0.91
Cyclosporine--high-dose steroid interaction in renal transplant recipients: assessment by HPLC. Transplant Proc (1987) 0.91
Cyclosporine G Analysis and Monitoring by High-Pressure Liquid Chromatography. Transplant Proc (1986) 0.91
The effect of food on cyclosporine absorption. Transplantation (1985) 0.91
The formation of neural codes in the hippocampus: trace conditioning as a prototypical paradigm for studying the random recoding hypothesis. Biol Cybern (2005) 0.90
Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatment. Eur J Pharmacol (2011) 0.90
FK506 and pregnancy in liver transplant patients. Transplantation (1993) 0.90
The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out mice. Bone (2007) 0.90
The kinetics of cyclosporine and its metabolites in bone marrow transplant patients. Br J Clin Pharmacol (1991) 0.89
In vivo effect of FK506 on human pancreatic islets. Transplantation (1991) 0.89
Serotype C foot-and-mouth disease virus isolates from India belong to a separate so far not described lineage. Vet Microbiol (2003) 0.89
Troglitazone increases cytochrome P-450 3A protein and activity in primary cultures of human hepatocytes. Drug Metab Dispos (1999) 0.89
Cyclosporine trough concentration monitoring in liver transplant patients. Transplant Proc (1986) 0.88
Cyclosporine metabolites. Transplantation (1987) 0.88
Acute hemodynamic effects of FK 506 during and after orthotopic liver transplantation. Transplant Proc (1990) 0.88
Cyclosporine metabolite concentrations in the blood of liver, heart, kidney, and bone marrow transplant patients. Transplant Proc (1988) 0.88
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. Transplant Proc (1992) 0.87
Effect of liver dysfunction on cyclosporine pharmacokinetics. Transplant Proc (1987) 0.86
Treprostinil, a prostacyclin analog, ameliorates ischemia-reperfusion injury in rat orthotopic liver transplantation. Am J Transplant (2011) 0.86
Interaction between FK506 and clotrimazole in a liver transplant recipient. Transplantation (1991) 0.86
Separation of cyclosporine metabolites: evaluation of high pressure liquid chromatographic column performance. Ther Drug Monit (1988) 0.86
Status of foot-and-mouth disease in India. Transbound Emerg Dis (2012) 0.86
Interaction between tacrolimus and erythromycin. Lancet (1994) 0.86
Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin. Transplant Proc (1991) 0.86
Pharmacokinetics of ritodrine administered intravenously: recommendations for changes in the current regimen. Am J Obstet Gynecol (1990) 0.85
Distribution of FK 506 in plasma lipoproteins in transplant patients. Transplant Proc (1991) 0.85
Sequence analysis of the non-structural 3A and 3C protein-coding regions of foot-and-mouth disease virus serotype Asia1 field isolates from an endemic country. Vet Microbiol (2006) 0.85
Current opinions on therapeutic drug monitoring of immunosuppressive drugs. Clin Ther (1999) 0.85
Drug-binding proteins in liver transplant patients. J Clin Pharmacol (1988) 0.84
Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients. Am J Transplant (2006) 0.84
Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. Transplantation (1995) 0.84
Interaction between FK 506 and cyclosporine in dogs. Transplant Proc (1991) 0.84
Species differences in the hepatic and intestinal metabolism of cyclosporine. Xenobiotica (1999) 0.84
Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus. J Clin Pharmacol (2001) 0.84
Tacrolimus analysis: a comparison of different methods and matrices. Ther Drug Monit (1995) 0.83
Strategy of FK 506 therapy in liver transplant patients: effect of graft function. Transplant Proc (1991) 0.83
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. Am J Hosp Pharm (1992) 0.83
Phylogeny, genome evolution, and antigenic variability among endemic foot-and-mouth disease virus type A isolates from India. Arch Virol (2005) 0.83